Arachidonic Acid-Dependent Phosphorylation of Troponin I and Myosin Light Chain 2 in Cardiac Myocytes

• Published in: Circulation research Vol. 76; no. 6; pp. 1011 - 1019
• Main Authors: Damron, Derek S, Darvish, Ahmad, Murphy, LeeAnn, Sweet, Wendy, Moravec, Christine S, Bond, Meredith
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD American Heart Association, Inc 01-06-1995; Lippincott; Lippincott Williams & Wilkins Ovid Technologies
• Subjects: Actin Cytoskeleton - drug effects; Actin Cytoskeleton - metabolism; Animals; Arachidonic Acid - metabolism; Arachidonic Acid - pharmacology; Biological and medical sciences; Blotting, Western; Calcium - metabolism; Endothelins - pharmacology; Enzyme Activation; Fundamental and applied biological sciences. Psychology; Heart; Heart Ventricles - cytology; Heart Ventricles - drug effects; In Vitro Techniques; Myocardial Contraction; Myocardium - cytology; Myocardium - metabolism; Myofibrils - drug effects; Myofibrils - metabolism; Myosins - analysis; Myosins - metabolism; Oxazoles - pharmacology; Phosphoprotein Phosphatases - antagonists & inhibitors; Phosphorylation; Protein Kinase C - metabolism; Rabbits; Rats; Tetradecanoylphorbol Acetate - pharmacology; Troponin - analysis; Troponin - metabolism; Troponin I; Vertebrates: cardiovascular system; Heart; Myofibril; Phosphorylation; Protein kinase C; Endothelin; Rat; Enzyme; Rodentia; Contractility; Contractile protein; Heart ventricle; Arachidonic acid; Light peptide chain; Myocyte; Vertebrata; Troponin; Mammalia; Myosin; Circulatory system
• ISSN: 0009-7330; 1524-4571
• DOI: 10.1161/01.RES.76.6.1011

Recent evidence has suggested that arachidonic acid (AA) may be an important signaling molecule in cardiac excitation-contraction coupling. We previously showed that AA and endothelin-1 (ET) inhibit distinct K channels via protein kinase C-dependent pathways in rat ventricular myocytes. In addition, we demonstrated that Ca plus transients in populations of fura 2-loaded myocytes were potentiated by AA and ET via activation of protein kinase C. In this study, we have used suspensions of [() P]orthophosphate () Pi)-labeled rat ventricular myocytes to study the effects of AA and ET at the level of the myofilaments. After a 10-minute incubation of the labeled cells with phorbol 12-myristate 13-acetate (PMA), AA, or ET in the presence or absence of the protein kinase C inhibitor calphostin C, the myofibrillar proteins were separated by PAGE. Measurement of unloaded cell shortening using video edge detection in single electrically stimulated myocytes was also used to assess the effects of AA and ET on myocyte contractility. Incubation with either PMA, AA, or ET resulted in similar increases in Pi incorporation into troponin I (TnI) and myosin light chain 2 (MLC2), which was inhibited by preincubation with the protein kinase C antagonist calphostin C. In addition, the ability of these agonists to stimulate phosphorylation of TnI or MLC2 did not require extracellular Ca plus or intact intracellular Ca plus stores. The effects of AA and ET together on phosphorylation of TnI or MLC2 were not additive. These results show that AA and ET phosphorylate myofibrillar proteins in intact cardiac myocytes via a calphostin C-inhibitable Ca plus-independent pathway and that AA, like ET, stimulates a positive inotropic effect in cardiac myocytes. Thus, phosphorylation of cardiac myofilaments by AA and/or ET, in addition to phosphorylation-dependent inhibition of distinct K channels, may represent an important signaling pathway by which AA and ET influence the inotropic state of the heart.(Circ Res. 1995;76:1011-1019.)